News agencies recently aired a report that a human study was suddenly halted due to safety concerns over the combined use of a drug, SRT501 modeled after resveratrol, combined with a toxic chemotherapy cancer drug, bortezomib (Velcade), among patients with myeloma (bone marrow cancer). The combination of drugs was suggested by researchers in attempt to [...]




